View All Questions

This is a really common question, especially for women and adults who notice their ADHD feels worse at certain points in the month. Clinically, we usually look at timing and pattern. ADHD tends to be more consistent across life, even if it varies with stress, sleep, and environment. Hormonal shifts often create a more cyclical pattern. You might notice that focus, energy, emotional regulation, or motivation dip predictably before your period, around ovulation, during perimenopause, or with changes in contraception. The tricky part is that it’s often not either or. Hormones can amplify underlying ADHD. So the ADHD is still there, but your usual coping strategies suddenly stop working because your baseline energy and regulation have dropped during this period of time. A simple tracking approach can help. For one or two cycles, note sleep, mood, focus, impulsivity, fatigue, and where you are in your cycle. You don’t need a perfect chart. Even a few notes like “brain fog worse” or “couldn’t start tasks” can help reveal patterns that can be highly informative to you and your provider. Clinicians also look at what improves symptoms. If things get better when sleep, pain, PMS symptoms, or cycle related changes settle, hormones may be playing a big role. If the same struggles persist all month, ADHD is more likely to be central. Either way, you’re not imagining it. Fluctuating executive function is real, and understanding the pattern helps us support it more precisely instead of blaming you for being inconsistent.

Yes, PTSD can make ADHD symptoms harder to treat, and it often changes how clinicians prioritise care. Trauma symptoms such as hypervigilance, intrusive thoughts, emotional reactivity, sleep disturbance, and dissociation can significantly impair attention, memory, and executive functioning. In many cases, these trauma-related difficulties are more impairing than ADHD itself and can closely mimic or amplify ADHD symptoms. When ADHD and PTSD co-exist, ADHD is usually pre-existing rather than caused by trauma. Many individuals likely functioned reasonably well with their ADHD before the traumatic experiences, and it is the onset of PTSD that leads to a marked decline in concentration, motivation, and daily functioning and therefore, leads them to seek help. For this reason, clinicians often prioritise treating active PTSD symptoms first, with the aim of helping the person return to their previous baseline level of functioning. Once trauma symptoms are better stabilised, it becomes much clearer whether ADHD continues to cause clinically significant impairment and requires targeted treatment. That said, ADHD does not need to be ignored entirely. In some cases, partial or cautious ADHD management can be helpful, particularly if inattention or organisational difficulties interfere with trauma therapy or daily stability. Any medication approach is typically gradual, conservative, and closely monitored, as stimulants can sometimes exacerbate anxiety or hyperarousal in untreated PTSD. Overall, effective treatment requires a phased and integrated approach—addressing trauma first where it is the primary driver of impairment, while reassessing ADHD needs once emotional and physiological safety has been restored.

Concentration difficulties are common and significant symptoms in both ADHD and anxiety, but clinicians try to understand why someone is experiencing attention issues. While it can feel similar from the inside, the drivers are often different, and careful history-taking usually clarifies this over time. In ADHD, inattention tends to be longstanding and situational. It often starts in childhood and is most noticeable during tasks that require sustained attention, sitting still, or mental effort. Thoughts may jump quickly between topics, but they are not necessarily threat-based or worry-focused. In anxiety, inattention is more closely tied to physiological arousal and worry. The thoughts are often racing and about potential problems, “what if” scenarios, or a sense that something bad might happen. The inattention is typically driven by fear or anticipation and it may persist even when a person wants to relax. Clinicians look at the timing, triggers, thought content, and emotional tone of the attention issues, as well as associated symptoms such as sleep disturbance, avoidance, or physical anxiety symptoms. Importantly, this is not always an either/or decision. People can have both ADHD and anxiety, and distinguishing their relative contributions may require repeated assessments over time, observation of response to treatment, and psychological formulation rather than a single appointment.

Adults taking medication for ADHD do not require a rigid or mandatory long-term monitoring protocol, but good clinical practice supports regular physical health review to ensure safety, tolerability, and ongoing benefit. Monitoring is proportionate to the medication used, the individual’s medical risk factors, and clinical response. Before starting treatment, baseline measures typically include blood pressure, heart rate, weight, and a brief cardiovascular history, including personal or family history of cardiac disease. An ECG is not routinely required in healthy adults but may be appropriate if there are cardiac symptoms, significant risk factors, or concerning findings. Once treatment is established, blood pressure and pulse are usually monitored periodically, particularly during titration and dose changes, as stimulants and some non-stimulants can cause modest increases in heart rate or blood pressure. Weight and appetite should also be reviewed, especially if there are concerns about weight loss, reduced intake, or gastrointestinal side effects. Ongoing follow-up appointments provide an opportunity to assess sleep, headaches, palpitations, and other physical symptoms that may emerge over time. For patients with comorbid medical conditions such as hypertension, anxiety disorders, or cardiovascular risk factors, closer monitoring may be appropriate. Routine blood tests are not required solely due to ADHD medication use unless clinically indicated. Importantly, physical monitoring should be integrated with functional review—assessing whether the medication continues to meaningfully improve attention, daily functioning, and quality of life.

Hormone replacement therapy can influence ADHD symptoms because hormones like estrogen and progesterone play a major role in mood, attention, and how the brain responds to stimulant medication. Estrogen generally supports cognitive clarity, working memory, and emotional stability, so stabilizing estrogen through HRT may help some people feel more focused or notice smoother medication effects. Progesterone can have the opposite impact for certain individuals, sometimes increasing brain fog, irritability, or low motivation. Because HRT shifts these hormone levels, some people experience changes in attention, mood, or how strong their ADHD medication feels. These effects aren’t universal, but they reflect how closely hormones and neurotransmitters interact. HRT doesn’t treat ADHD directly, yet it can change the overall landscape in which ADHD symptoms show up, sometimes making them easier or harder to manage depending on the person.

This can feel confusing because there is overlap. ADHD burnout often follows prolonged effort to compensate. It shows up as mental exhaustion, irritability, and reduced capacity, but interest and mood may still lift with rest or stimulation. Depression tends to involve persistent low mood, loss of pleasure, hopelessness, sleep and appetite changes, and a more global sense of heaviness. We look at duration, emotional tone, and whether motivation returns in preferred activities. Sometimes both are present. Chronic untreated ADHD can increase risk of depression over time. If flatness has lasted months and affects multiple areas of life, it deserves a proper evaluation. You do not have to figure it out alone.

You are definitely not alone. Many people notice increased emotional sensitivity as ADHD medication wears off, often called a “crash” or rebound effect. As stimulant levels fall, the brain can briefly swing from a more regulated state to one where emotional control, frustration tolerance, and stress buffering drop off. This can show up as tearfulness, irritability, feeling overwhelmed, or reacting more strongly to small things. It is a physiological effect of the medication leaving your system, not a personal failing or “being dramatic.” That said, not everyone experiences this, and when it does happen, clinicians take it seriously. A pronounced crash can mean the dose is a little too high, the medication is wearing off too abruptly, or the formulation is not the best fit for your metabolism. It can also be more noticeable on days with poor sleep, high stress, or skipped meals. There are practical ways to manage this. Non-medication strategies include planning lower-demand activities during the wear-off window, eating a protein-containing snack, hydrating well, and building in intentional self-care rather than high-stakes tasks. From a medication perspective, options may include adjusting the dose, splitting doses, or switching to a longer-acting or smoother formulation. If the emotional drop-off is frequent or distressing, it is worth discussing with your prescriber. The goal is not just focus during peak hours, but a medication plan that supports emotional steadiness across the day.

In practice, masking in ADHD almost always involves both behaviour and emotion, even though people tend to talk about the behavioural part more openly. Behavioural masking is the most visible. Adults describe forcing themselves to sit still, monitoring how much they talk, suppressing fidgeting, making eye contact, double-checking emails, or over-preparing so they don’t appear scattered. This kind of masking is often learned early, especially by people who were repeatedly corrected or told to “try harder.” Emotional masking is just as significant, and often more exhausting. Many adults with ADHD work very hard to hide frustration, overwhelm, boredom, rejection sensitivity, or emotional reactivity. They may smile through meetings while internally panicking, downplay how overstimulated they feel, or suppress emotional responses to avoid being seen as “too much.” Over time, this creates a constant gap between how they feel and how they present. When I talk about masking with adult patients, I frame it as an adaptation, not a flaw. Masking usually develops because it worked. It helped someone stay employed, avoid criticism, or fit in socially. The problem isn’t that people learned to mask, it’s that doing it nonstop comes at a cost. Chronic fatigue, irritability, emotional numbness, and after-work crashes are often signs of long-term masking. Clinically, we explore where masking is protective and where it’s draining. The goal isn’t to unmask everywhere or all at once. It’s to reduce unnecessary masking and build environments where less of it is required. Many adults feel relief just realizing they’re not “failing at adulthood,” they’ve been performing it. Understanding masking helps patients be more compassionate with themselves and make choices that support sustainability, not just survival.

Very carefully and collaboratively. Chronic pain and fatigue can mimic or worsen attention difficulties. We first clarify what is driving what. Sometimes low dose stimulant treatment helps energy and cognitive clarity. Other times it may exacerbate symptoms if sleep is disrupted. We prioritize sleep, pacing, and nervous system regulation. Medication decisions are individualized and conservative. The goal is improving function without increasing physical stress. It often requires more frequent follow up and small adjustments rather than big changes.

Yes, very often. Girls with inattentive ADHD may be dreamy, disorganized, or internally overwhelmed rather than disruptive. Because they are not causing classroom issues, symptoms can be overlooked. Many compensate with perfectionism or anxiety. They may not be identified until academic demands increase. Quiet does not mean coping well. We have to look at effort and internal experience.